Skip to main content
logo
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
54.55
-1.20 (-2.15%)
At close: Feb 13, 2026

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21
Biopharmaceutical Research & Development and Commercialisation
464.18M
Biopharmaceutical Research & Development and Commercialisation Growth
18.63%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Year Ending
Dec '24 Dec '23 Dec '22 Dec '21
Overseas
424.09M
Overseas Growth
8.67%
China
40.09M
China Growth
3917.60%